000650.SZ · 仁和药业
China A-shares · RS rating 62 · As of 2026-10-14
| Price | 5.22 CNY |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 65 / 51 / 45 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 18 / 24 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +60.6% |
| Distance from 52-week high | +18.2% |
| Market cap (USD) | $1.1B |